01 4Pfizer Canada Inc.
02 4Pfizer Canada ULC
01 22284977
02 22328920
03 22389749
04 22652712
01 8Fesoterodine Fumarate
01 8Extended Release Tablet
01 22018-03-26
02 22019-05-11
03 22020-11-15
04 22027-06-06
Patent Expiration Date : 2020-11-15
Date Granted : 2009-03-31
Brand Name : TOVIAZ
Patent Number : 2389749
Filing Date : 2000-11-15
Strength per Unit : 4 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-15
Date Granted : 2009-03-31
Patent Expiration Date : 2019-05-11
Date Granted : 2008-04-15
Brand Name : TOVIAZ
Patent Number : 2328920
Filing Date : 1999-05-11
Strength per Unit : 4 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-11
Date Granted : 2008-04-15
Patent Expiration Date : 2018-03-26
Date Granted : 2008-02-05
Brand Name : TOVIAZ
Patent Number : 2284977
Filing Date : 1998-03-26
Strength per Unit : 4 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-26
Date Granted : 2008-02-05
Patent Expiration Date : 2027-06-06
Date Granted : 2014-04-01
Brand Name : TOVIAZ
Patent Number : 2652712
Filing Date : 2007-06-06
Strength per Unit : 4 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-06-06
Date Granted : 2014-04-01
Patent Expiration Date : 2020-11-15
Date Granted : 2009-03-31
Brand Name : TOVIAZ
Patent Number : 2389749
Filing Date : 2000-11-15
Strength per Unit : 8 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-15
Date Granted : 2009-03-31
Patent Expiration Date : 2019-05-11
Date Granted : 2008-04-15
Brand Name : TOVIAZ
Patent Number : 2328920
Filing Date : 1999-05-11
Strength per Unit : 8 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-11
Date Granted : 2008-04-15
Patent Expiration Date : 2018-03-26
Date Granted : 2008-02-05
Brand Name : TOVIAZ
Patent Number : 2284977
Filing Date : 1998-03-26
Strength per Unit : 8 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-26
Date Granted : 2008-02-05
Patent Expiration Date : 2027-06-06
Date Granted : 2014-04-01
Brand Name : TOVIAZ
Patent Number : 2652712
Filing Date : 2007-06-06
Strength per Unit : 8 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-06-06
Date Granted : 2014-04-01
